No Data
No Data
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Appili Therapeutics Brief: Says Definitive Agreement With Aditxt, If Approved by Appili Shareholders, "Provides Significant Premium to Shareholders and Resources to Advance Key Programs"
Appili Therapeutics Brief: Notes U.S. Food and Drug Administration Meeting Request Submitted to Discuss ATI-1801 Registration Strategy
Express News | Aditxt Inc - Transaction Is Conditional Upon Aditxt Raising at Least US$20 Mln in Financing Before Closing
Aditxt Signs Second Amendment to the Arrangement Agreement With Appili Therapeutics, Targeting September 30 Closing of the Acquisition
Appili Therapeutics Q4 Loss Narrows Amid Increase in Government Assistance
No Data